This public procurement record has 1 release in its history.

Planning

11 Nov 2026 at 12:24

Summary of the contracting process

King’s College Hospital NHS Foundation Trust is exploring a tissue and cell management system for its stem cell transplantation and cellular therapy laboratory services. The system is intended to manage and trace cellular therapy products end to end, from donor and patient registration through collection, processing, cryopreservation, storage, issue and administration. Required functions include compliant product labelling, a secure audit trail, quality management of deviations and non-conformances, inventory and storage-location management, and reporting. The service is delivered in London. The Trust currently uses a commercial system and is considering continuity options, including upgrading or migrating it, or adopting an alternative. The work is medical software and associated implementation and support services (CPV 48814000).

This is preliminary market engagement at the planning stage, not an invitation to tender. The Trust is gathering information on available systems, supplier interest, delivery models, interfaces, implementation, indicative costs and possible routes to market. Responses will not be scored and will not affect participation in any later competition; any pricing is non-binding and for budgeting only. Suppliers are asked to register interest by 26 November 2026 and complete a questionnaire. The Trust expects a future procurement notice around 11 January 2027, subject to its decision on the route to market. The planning estimate is £375,000 excluding VAT (£450,000 including VAT). The intended contract period is 3 May 2027 to 2 May 2032, with possible extension to 1 May 2034. One lot is planned; SMEs are considered suitable.

This engagement is relevant to suppliers of specialist laboratory information systems for cellular therapy, including providers able to support deployment, migration, validation and ongoing system upgrades. The system must support ICCBBA ISBT 128 labelling and traceability, Human Tissue Authority licensing and FACT-JACIE accreditation. Electronic records and traceability must align with GAMP 5, GMP Annex 11 and 21 CFR Part 11, as well as MHRA data-integrity expectations. The Trust requires supplier support for installation and operational and performance qualification before go-live, plus controlled upgrades that minimise revalidation. Suppliers should be ready to explain hosted, cloud or on-premise options, Microsoft infrastructure compatibility and live UK interfaces with Epic or other electronic patient record systems. Relevant experience with data migration and implementation in regulated healthcare settings will help suppliers assess fit and prepare for a potential formal competition. All suppliers will have the same opportunity to demonstrate a solution if demonstrations are requested.

How relevant is this notice?

Notice Information

Notice Title

PME for Tissue and Cell Management System

Notice Description

King's College Hospital NHS Foundation Trust ("the Trust") is carrying out preliminary market engagement under the Procurement Act 2023 to understand the solutions available for a tissue and cell management system supporting its stem cell transplantation and cellular therapy laboratory services. The Trust currently uses a commercial off-the-shelf tissue and cell management system, in live use since 2023. The infrastructure on which it runs reaches end of support in January 2027, and the Trust is assessing its options for continuity of service from 2027. These include upgrading or migrating the existing solution and adopting an alternative solution. The purpose of this engagement is to establish which providers of this type of system exist in the market, and their level of interest, to help the Trust decide on the most appropriate route to market and timescales. The outcome will inform the Trust's requirements, options appraisal and business case, and the Trust anticipates that it will be followed by a formal procurement. The Trust is seeking solutions that provide end-to-end management and traceability of cellular therapy products, from donor and patient registration through collection, processing, cryopreservation, storage, issue and administration. The solution will need to support: * labelling and traceability in line with ICCBBA ISBT 128 standards; * a complete and secure audit trail; * quality management, including deviations and non-conformances; * inventory and storage location management; and * reporting. The solution will need to enable the service to meet Human Tissue Authority (HTA) licensing requirements and FACT-JACIE accreditation standards. It should also meet electronic record and traceability requirements under GAMP 5, GMP Annex 11 (Computerised Systems) and 21 CFR Part 11, and comply with MHRA data integrity expectations. Supplier support for installation, operational and performance qualification (IQ/OQ/PQ) will be required before go-live, together with an approach to upgrades after go-live that controls system changes and minimises the revalidation burden. The Trust is particularly interested in understanding the following: * which suppliers offer a solution that can meet these requirements, and any areas that would not be met; * deployment models (on-premise, supplier-hosted or cloud/SaaS), including whether solutions can be delivered on Microsoft-based infrastructure (Windows Server and Microsoft SQL Server) or as a fully hosted service; * whether suppliers have live interfaces with Epic or other electronic patient record systems in the UK; * typical implementation timescales, including validation and data migration; * indicative costs, to help inform the Trust's Outline Business Case; * whether the solution is available through an NHS England-approved framework agreement or dynamic market; and * whether suppliers would expect to take part in a competitive procurement, and their views on the Trust's proposed approach and indicative timescales.

Planning Information

Interested suppliers should register their interest via the Atamis tender portal. When registering, suppliers should provide their Central Digital Platform (CDP) supplier reference. Suppliers not yet registered on the Central Digital Platform should note that registration will be required to take part in any subsequent procurement. Registered suppliers will be issued must download the document 'PME Pack - Tissue and Cell Management System vFinal' which gives detail about the engagement and contains a short questionnaire to establish whether their solution can meet the Trust's key requirements, their likely interest in any future procurement and their views on the Trust's approach. A summary of the key requirements and an indicative tender timescale will be provided with the questionnaire. Suppliers are also invited to provide indicative, non-binding pricing, as ranges where appropriate, to help the Trust prepare its Outline Business Case. Any pricing provided will be used for budgeting purposes only, will not be evaluated, and will have no bearing on any future procurement. The Trust may also invite suppliers to give a demonstration of their solution; if so, details will be provided to all registered suppliers and every supplier will be offered the same opportunity. This notice does not commit the Trust to any procurement or route to market. Responses will not be scored, and participation or non-participation will not affect any supplier's ability to take part in any future procurement. The Trust will take all appropriate steps to ensure that no supplier gains an unfair advantage from this engagement. Information gathered may be used to inform the Trust's requirements and any future procurement documents.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-07b983
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/107075-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Framework
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

48 - Software package and information systems

72 - IT services: consulting, software development, Internet and support


CPV Codes

48180000 - Medical software package

48814000 - Medical information systems

72250000 - System and support services

72260000 - Software-related services

Notice Value(s)

Tender Value
£375,000 £100K-£500K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
11 Nov 20265 days ago
Submission Deadline
Not specified
Future Notice Date
11 Jan 20272 months to go
Award Date
Not specified
Contract Period
3 May 2027 - 2 May 2032 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
King’s College Hospital NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE5 9NY
Postcode Area
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLI4 Inner London - East

Local Authority
Lambeth
Electoral Ward
Herne Hill & Loughborough Junction
Westminster Constituency
Dulwich and West Norwood

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...